Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8029091rdf:typepubmed:Citationlld:pubmed
pubmed-article:8029091lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:8029091lifeskim:mentionsumls-concept:C0005767lld:lifeskim
pubmed-article:8029091lifeskim:mentionsumls-concept:C0035344lld:lifeskim
pubmed-article:8029091lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:8029091lifeskim:mentionsumls-concept:C0344395lld:lifeskim
pubmed-article:8029091lifeskim:mentionsumls-concept:C1287365lld:lifeskim
pubmed-article:8029091pubmed:issue1lld:pubmed
pubmed-article:8029091pubmed:dateCreated1994-8-8lld:pubmed
pubmed-article:8029091pubmed:abstractTextRetinopathy of prematurity (ROP) is a multifactorial disease where production of free radicals is a pathogenic factor. Bilirubin is regarded today as the most powerful antioxidant substance "in vitro". To test such effect "in vivo" we studied 219 premature infants, admitted to our Neonatal Intensive Case Unit from April 1991 to October 1992, evaluating their serum bilirubin levels from day two to seven and mean bilirubin level of first week for each child. We also calculated the mean rate of daily increase of bilirubin. Our results show that bilirubin parameters considered are higher in neonates which will develop ROP of every stage than in the control ones. These results therefore do not support the concept that bilirubin could have a role in the prevention of ROP.lld:pubmed
pubmed-article:8029091pubmed:languageitalld:pubmed
pubmed-article:8029091pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8029091pubmed:citationSubsetIMlld:pubmed
pubmed-article:8029091pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8029091pubmed:statusMEDLINElld:pubmed
pubmed-article:8029091pubmed:issn0391-5387lld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:DistefanoGGlld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:RoletJ FJFlld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:Di PietroMMlld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:ScuderiAAlld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:CaraccioliKKlld:pubmed
pubmed-article:8029091pubmed:authorpubmed-author:TinaL GLGlld:pubmed
pubmed-article:8029091pubmed:issnTypePrintlld:pubmed
pubmed-article:8029091pubmed:volume16lld:pubmed
pubmed-article:8029091pubmed:ownerNLMlld:pubmed
pubmed-article:8029091pubmed:authorsCompleteYlld:pubmed
pubmed-article:8029091pubmed:pagination59-62lld:pubmed
pubmed-article:8029091pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:meshHeadingpubmed-meshheading:8029091-...lld:pubmed
pubmed-article:8029091pubmed:articleTitle[Variations of blood bilirubin levels in the newborn with and without retinopathy of prematurity (ROP)].lld:pubmed
pubmed-article:8029091pubmed:affiliationCattedra di Neonatologia, Università di Catania, Italia.lld:pubmed
pubmed-article:8029091pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8029091pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8029091pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8029091pubmed:publicationTypeEnglish Abstractlld:pubmed